Skip to content

Effects of Milk Derived From Mountain-pasture Grazing Cows on Risk Markers of the Metabolic Syndrome Compared to Conventional Danish Milk

Effects of Milk Derived From Mountain-pasture Grazing Cows on Risk Markers of the Metabolic Syndrome Compared to Conventional Danish Milk

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01343589
Enrollment
38
Registered
2011-04-28
Start date
2010-01-31
Completion date
2010-06-30
Last updated
2011-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Heart Disease, Type-2 Diabetes

Brief summary

To investigate the effect of milk delivered from mountain-pasture grazing cows on risk markers of the metabolic syndrome and type-2 diabetes with the effect of conventional Danish milk. The study should reveal the importance of phytanic acid content for these effects.

Interventions

DIETARY_SUPPLEMENTmilk fat

39 g milk fat per day in 12 weeks

Sponsors

The Danish Dairy Research Foundation, Denmark
CollaboratorOTHER
The Danish Council for Strategic Research
CollaboratorOTHER
University of Copenhagen
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
50 Years to 70 Years
Healthy volunteers
Yes

Inclusion criteria

* sign written consent * Age: 50-70 * BMI: 20-30 * increased risk of developing MS * refrain from dietary supplements and blood donations prior to, and during the study

Exclusion criteria

* poor compliance * if they suffering from any chronic or long lasting illness * abuse of alcohol or medicine

Design outcomes

Primary

MeasureTime frame
fatty acid composition in plasmabefore and after the intervention (12 weeks)
Oral glucose tolerance testbefore and after the intervention (12 weeks)
LDL cholesterolbefore and after the intervention (12 weeks)
HDL cholesterolbefore and after the intervention (12 weeks)
Total cholesterolbefore and after the intervention (12 weeks)
Triacylglycerolbefore and after the intervention (12 weeks)
C-reactive proteinbefore and after the intervention (12 weeks)

Secondary

MeasureTime frame
phytanic acidbefore and after the intervention (12 weeks)

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 23, 2026